How GE Healthcare is investing in medtech innovation

December 2, 2019 By Chris Newmarker

GE Healthcare (NYSE:GE) appears to be taking the “throw it against the wall and see what sticks” approach when it comes to medtech innovation.

GE’s Chicago-based healthcare subsidiary today announced a medtech 3D printing partnership with Formlabs (Somerville, Mass.). GE Healthcare also disclosed its participation in the recent $243 million Series C round of robot-assisted surgery device maker CMR Surgical (Cambridge, U.K.), and the company is investing an undisclosed sum into Decisio Health (Houston) and its clinical surveillance software that provides real-time, consolidated view of patients from multiple systems across a health provider network.

The news comes about a week after GE Healthcare touted the launch of its Edison Developer Program for accelerating the adoption and impact of artificial intelligence applications and developer services across health systems.

Get the full story on our sister site MassDevice.

About The Author

Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at [email protected].